Natraj Proteins Limited (BOM:530119)
India
· Delayed Price · Currency is INR 29.56
-1.59 (-5.10%)
At close: Mar 9, 2026
Natraj Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,053 | 1,178 | 1,937 | 1,436 | 1,447 | 1,462 | Upgrade
|
| Other Revenue | 0 | - | - | - | - | - | Upgrade
|
| Revenue | 1,053 | 1,178 | 1,937 | 1,436 | 1,447 | 1,462 | Upgrade
|
| Revenue Growth (YoY) | -21.16% | -39.20% | 34.91% | -0.77% | -1.03% | -5.13% | Upgrade
|
| Cost of Revenue | 958.85 | 1,099 | 1,945 | 1,334 | 1,232 | 1,353 | Upgrade
|
| Gross Profit | 94.22 | 78.78 | -7.31 | 101.89 | 215.07 | 109.47 | Upgrade
|
| Selling, General & Admin | 11.7 | 13.14 | 13.03 | 11.85 | 13.94 | 11.83 | Upgrade
|
| Other Operating Expenses | 44.92 | 54.49 | 73.32 | 59 | 59.52 | 66.79 | Upgrade
|
| Operating Expenses | 60.01 | 71.08 | 90.83 | 75.12 | 77.42 | 82.65 | Upgrade
|
| Operating Income | 34.21 | 7.7 | -98.13 | 26.77 | 137.65 | 26.83 | Upgrade
|
| Interest Expense | -22.15 | -22.66 | -27.11 | -16.97 | -9.16 | -17.47 | Upgrade
|
| Interest & Investment Income | 2.3 | 2.3 | 2.03 | 2.06 | 2.1 | 1.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.83 | 0.6 | -2.37 | -1.76 | -1.2 | -0.64 | Upgrade
|
| EBT Excluding Unusual Items | 15.19 | -12.07 | -125.58 | 10.1 | 129.39 | 9.78 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.31 | 0.31 | 0.96 | 0.08 | 0.17 | - | Upgrade
|
| Pretax Income | 15.5 | -11.77 | -124.63 | 10.18 | 129.56 | 9.78 | Upgrade
|
| Income Tax Expense | 2.62 | 2.86 | 0.56 | 3.05 | 35.94 | 5.84 | Upgrade
|
| Net Income | 12.88 | -14.63 | -125.19 | 7.13 | 93.62 | 3.94 | Upgrade
|
| Net Income to Common | 12.88 | -14.63 | -125.19 | 7.13 | 93.62 | 3.94 | Upgrade
|
| Net Income Growth | - | - | - | -92.38% | 2279.21% | 16.12% | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| EPS (Basic) | 3.39 | -3.90 | -33.41 | 1.90 | 24.99 | 1.05 | Upgrade
|
| EPS (Diluted) | 3.39 | -3.90 | -33.41 | 1.90 | 24.99 | 1.05 | Upgrade
|
| EPS Growth | - | - | - | -92.40% | 2279.61% | 16.67% | Upgrade
|
| Free Cash Flow | - | 209.11 | -56.95 | 6.54 | 40.46 | 85.22 | Upgrade
|
| Free Cash Flow Per Share | - | 55.81 | -15.20 | 1.75 | 10.80 | 22.74 | Upgrade
|
| Gross Margin | 8.95% | 6.69% | -0.38% | 7.09% | 14.86% | 7.49% | Upgrade
|
| Operating Margin | 3.25% | 0.65% | -5.07% | 1.86% | 9.51% | 1.84% | Upgrade
|
| Profit Margin | 1.22% | -1.24% | -6.46% | 0.50% | 6.47% | 0.27% | Upgrade
|
| Free Cash Flow Margin | - | 17.75% | -2.94% | 0.46% | 2.80% | 5.83% | Upgrade
|
| EBITDA | 36.82 | 11.07 | -93.74 | 31 | 141.61 | 30.85 | Upgrade
|
| EBITDA Margin | 3.50% | 0.94% | -4.84% | 2.16% | 9.79% | 2.11% | Upgrade
|
| D&A For EBITDA | 2.6 | 3.37 | 4.39 | 4.23 | 3.96 | 4.02 | Upgrade
|
| EBIT | 34.21 | 7.7 | -98.13 | 26.77 | 137.65 | 26.83 | Upgrade
|
| EBIT Margin | 3.25% | 0.65% | -5.07% | 1.86% | 9.51% | 1.84% | Upgrade
|
| Effective Tax Rate | 16.92% | - | - | 29.96% | 27.74% | 59.76% | Upgrade
|
| Revenue as Reported | 1,058 | 1,183 | 1,940 | 1,437 | 1,450 | 1,463 | Upgrade
|
| Advertising Expenses | - | - | - | 0.01 | 0.01 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.